Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein A1 is a DNA-binding transcription factor characterized by a forkhead domain that enables binding to the major groove of DNA and direct contact via its "wing" structures. As a "pioneer factor," FOXA1 facilitates the opening of compacted chromatin, allowing other transcription regulatory proteins, such as hormone receptors, to access DNA. It plays crucial roles in the differentiation and function of endodermal organs (liver, pancreas, lung, prostate) and is essential during development. FOXA1 is a pivotal regulator of hormone receptor signaling in breast and prostate tissue, heavily studied for its involvement in tumor progression, response to therapy, and cancer resistance mechanisms. FOXA1 is frequently mutated in prostate cancer, and its expression correlates both with favorable response in some breast tumors and with resistance and poor prognosis in others
Indirect; regulates hormone receptor pathways thus affects drug sensitivity/resistance
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein A1 (FOXA1).